IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NAMSW

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q2 2023Q4 2022
Cash & Equivalents424.15457.61490.00538.41563.86748.42771.74--------383.50438.52
Short-term Investments209.70178.50146.24164.54175.3060.0662.45------------
Total Current Assets659.21658.04675.70732.33769.85817.30863.41437.87445.35487.82346.79389.26448.13
Property, Plant & Equipment0.410.380.380.320.310.240.240.230.230.100.05----
Total Non-current Assets*45.2574.6093.5854.1045.261.111.211.321.340.640.3181.8383.45
Total Assets704.45732.64769.28786.43815.11818.41864.62439.19446.69488.46347.10----
Accounts Payable5.428.098.973.635.906.094.747.045.288.5416.92----
Total Current Liabilities72.9767.4285.7958.2736.5140.91106.9241.2645.3159.7349.9038.3435.46
Total Non-current Liabilities*0.060.000.070.090.100.140.2019.0713.9416.938.8110.5011.60
Total Liabilities73.0367.4285.8558.3636.6241.05107.1260.3359.2576.6658.70----
Retained Earnings(874.97)(810.83)(762.39)(687.47)(615.46)(598.10)(558.57)(466.39)(449.75)(410.74)(316.97)----
Total Stockholder Equity631.42665.22683.43728.07778.50777.36757.50378.86387.44411.80288.39422.26484.52
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q2 2023
Total Revenue3.703.040.030.3519.152.9812.7729.112.281.400.809.56
Research & Development41.6738.0138.5930.9727.5244.7534.9035.7038.3842.4341.29--
Selling, General & Admin3.872.723.992.764.314.323.6518.4116.4814.4510.59--
Total Operating Expenses68.5761.4666.0155.4954.7871.9056.0054.1154.8556.8851.8886.61
Operating Income(64.86)(58.42)(65.98)(55.14)(35.63)(68.92)(43.23)(25.00)(52.57)(55.48)(51.07)(77.05)
Pretax Income(64.14)(48.44)(74.92)(72.00)(17.36)(39.53)(92.18)(16.65)(39.01)(93.77)(49.47)(75.10)
Tax Provision---------------0.00--------
Net Income(64.14)(48.44)(74.92)(72.00)(17.36)(39.53)(92.18)(16.65)(39.01)(93.77)(49.49)(75.10)
Basic EPS(0.52)(0.40)(0.62)(0.61)(0.15)(0.34)(0.91)(0.18)(0.41)(1.06)(0.60)(0.92)
Diluted EPS(0.52)(0.40)(0.62)(0.61)(0.15)(0.34)(0.91)(0.18)(0.41)(1.06)(0.60)(0.92)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q2 2023
Operating Cash Flow(39.21)(30.60)(40.87)(32.77)(37.67)(36.47)(37.48)(12.50)(53.98)(54.60)(62.86)
Capital Expenditures0.080.040.100.040.090.020.000.080.210.39--
Free Cash Flow*(39.29)(30.64)(40.97)(32.81)(37.76)(36.48)(37.48)(12.58)(54.19)(54.99)--
Investing Cash Flow(4.76)(11.51)(21.14)2.51(159.14)2.86(62.18)(0.07)(0.21)(0.38)5.17
Financing Cash Flow11.0411.0713.685.893.436.52456.610.064.66198.188.02
← Scroll for more columns →

* Derived from reported values